This report provides exclusive insights into the COVID-19 impact on the Acute Kidney Injury Treatment Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Acute Kidney Injury Treatment Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Acute Kidney Injury Treatment Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
A recent report published by
Infinium Global Research on the acute kidney injury treatment market provides an in-depth analysis of segments and sub-segments in the global as well as
regional acute kidney injury treatment market. The study also highlights the impact
of drivers, restraints, and macro indicators on the global and regional acute
kidney injury treatment market over the short term as well as long term. The
report is a comprehensive presentation of trends, forecast and dollar values of
the global acute kidney injury treatment market. According to the report, the
global acute kidney injury treatment market is projected to grow at a CAGR of
7.2% over the forecast period of 2019-2025.
Acute kidney injuries occur due
to the building of waste products in the blood. Acute kidney injury causes
severe inflation and damage to the kidney. Acute kidney injuries are more
common among the geriatric population suffering from various other diseases.
Symptoms of acute kidney injuries include swelling in legs, ankles, less urine
discharge, and chest pain. The growth of the global healthcare sector
contributes to the treatment of acute kidney injuries.
The rising prevalence of acute
kidney injuries globally is a major factor contributing to the growth of the
acute kidney injury treatment market. As per the International Society of
Nephrology, every year there are around 13.3 million cases of acute kidney
injury. Additionally, 1.7 million deaths are caused by acute kidney injury per
year globally. Renal ultrasonography is the most appropriate and useful
radiologic test in the evaluation of patients suffering from acute kidney
injury. The development in renal ultrasonography required to find out the
reversible cause of acute injury stimulates the expansion of the acute kidney
injury treatment market. Additionally, favorable government initiatives for
creating awareness about acute kidney injury led to the rise in demand for
acute kidney injury treatment. The growing geriatric population worldwide is
one of cause for the rise in acute kidney injury treatment market. In 2017, the
global population aged 60 years and over is 962 million and expected to reach
nearly 2.1 billion by 2050. In addition, the surge in the number of clinical trials
of drugs to treat acute kidney injury, growing adoption of advanced
technologies and enhancement in healthcare services promotes the expansion of
the acute kidney injury treatment market. On the other side, the side effects
of drugs used in acute kidney injury treatment hamper the growth market.
Moreover, research and development promote innovations and advancements in
acute kidney injury treatment creating several opportunities for the growth of
Based on geography, the global
acute kidney injury treatment market is classified into North America, Asia-Pacific,
Europe, and the Rest of the World. North America is anticipated to have the
largest share in the global acute kidney injury treatment market. The
increasing diseases oriented drug research and the availability of
well-developed healthcare infrastructure in North America drives the growth of
the acute kidney injury treatment market in North America. Europe is expected
to be a lucrative region for the market. The enhanced healthcare infrastructure
in Europe stimulates the growth of the acute kidney injury treatment market in
Europe. Asia-Pacific region has healthy growth in the global acute kidney
injury treatment market due to the increasing patient pool and surges in
investments for better healthcare facilities in Asia-Pacific.
The report on global acute kidney
injury treatment market covers segments such as type, treatment, and end-user.
On the basis of type, the sub-markets include prerenal acute kidney injury,
postrenal acute kidney injury, and intrinsic renal acute kidney injury. On the
basis of treatment, the sub-markets include dialysis, and supportive care. On
the basis of end-user, the sub-markets include hospitals, ambulatory surgical
centers, and other end-users.
The report provides profiles of
the companies in the market such as Quark Pharmaceuticals, Inc., Baxter
International, Inc., AM-Pharma BV, LG Chem Ltd., Fresenius Medical Care AG
& Co. KGaA, Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Teva
Pharmaceutical Industries Ltd., Merck & Co., Inc., Novartis International
AG, and other companies.
The report provides deep insights
into the demand forecasts, market trends, and micro and macro indicators. In
addition, this report provides insights into the factors that are driving and
restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis
given in the report brings an insight into the investment areas that existing
or new market players can consider. The report provides insights into the
market using analytical tools such as Porter's five forces analysis and DRO
analysis of the acute kidney injury treatment market. Moreover, the study
highlights current market trends and provides forecast from 2019-2025. We also
have highlighted future trends in the market that will affect the demand during
the forecast period. Moreover, the competitive analysis given in each regional
market brings an insight into the market share of the leading players.